1/61
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
4 stages of the hemostatic mechanism
vasoconstriction, platelet activation, coagulation cascade, fibrinolysis/clot degradation
cells produced from megakaryocytes that live for 7-10days and whose external membranes contain glycoproteins and granules contain hormones, enzymes, and other chemicals
platelets
first role of platelets in primary hemostasis
adhesion (immediatly adhere to expose collagen and von willebrand factor acts as glue to buind platelets to collagen
2nd role of platelets in primary hemostasis
activation (calcoum makes platelets change shape and stick to each other and release their cytoplasmic granules which mediates aggregation.
how long does aspirin inhibit platelet function
for the whole life of the platelet
if your pt is on apririn what should you tell them before their coag studies are done
they need to be off the aspirin for 48-96hrs before hand so their studies dont get messed up
third role of platelets in primary hematostasis
aggregation (platelet recruiting and attach to other platelets to form a mesh network, platelet-to-platelet cross links stabilized by thrombospondin)
what clotting factors are included in the intrinsic pathway
12, 11, 9, 8
what clotting factors are included in the extrinsic pathway
7
what clotting factors are included in the common pathway
10, 5, 7, prothrombin, thrombin, fibrinogen
defects in hemostasis that can result in abnormal bleeding or clotting
injury to vascular system, inadequate platelets in number or fxn, inadequate clotting pathway mech (not enough clotting factors in cascade), inadequate fibrin clot formation, breakdown and repair
whats the first lab test we do for any blood problems/coagulation studies
CBC
possible causes for thrombocytosis (inc platelets)
myoproliferative disorders, reactive from hemorrhage, malignancy, infection, splenectomy
possible causes for thrombocytopenia (dec platelets)
bone marrow disorders, autoimmune disorders, liver disease
skin redness on pts w bleeding disorders doesnt ___
blanch
skin things you may see in pts w thrombocytopenia
petechiae, purpura, ecchymosis (all non-blanching)
most common cause of poor platelet function
secondary to meds (esp aspirin or clopidogrel)
possibel causes for poor platelet function (which may result in life threatning hemorrhages cause they cant clot)
hereditary, myloproliferative diseases, myelodysplastic disorders, uremia, liver dailure, renal failure, clotting factor deficiency
an automated assay of platelet function that measures time required to build a stable platelet plus and obstain full occlusion (simulated in vitro not tested on body) and reported in seconds
closure time
uses for closure time test
good for theraputic monitoring, not a screening test for bleeding risk, prolonged=bad
measurement of PLT aggregation to various activators in vitro that is recorded by a light transmission aggregometer (will initially look turbid and then clear as platelets aggregate)
platelet aggregation studies
how are platelet aggregation studies recorded
change in transmission of light is recorded as a function of time on a moving strip = looks like a response curve
gold standard in platelet function testing
platelet aggregation studies
the only platelet test that measures platelet function in the body and not in vitro
bleeding time test
a test that measures how long it takes body to stop bleeding by making 2 incisions and recording how long it takes for pt to stop bleeding
bleeding time test
types of coagulation tests
PT, PTT, INR
caogulation test that measures extrinsic and common pathways (factors 2, 5, 7, 10)
prothrombin time (PT)
what increases PT
prolonged in coagulation factor deficiencies
method of choice to monitor warfarin therapy
PT
what is a critical value for International Normalized Ratio (INR)
5+ (want it to be less than 3.5 if theyre on warfarin)
increasing INR=
increased anticoagulation
use for measuring PT
evaluate liver function (bc liver is where coagulation factors are made)
high PT causes
low vit K , liver disease, anti-coag therapy, DIC, hypothermia, massive blood diffusion , meds (erythromycin, allopurinol)
low PT causes
fresh frozen plasma transfusion, vit k supplementation, meds (PCN, doxycycline, rifampin (TB med), aspirin)
coagulation test that measures intrinsic and common pathways (factors 1, 2, 5, 8, 9, 10, 11, 12)
partial thromboplastin time (PTT or APTT)
causes of prolonged/high PTT
coagulation factor deficiency, hereditary, vit k deficiency, liver disease, anti-coagulatoin therapy
causes of shortened/lower PTT
DIC, severe hemorrhage, cancer
critical value for PTT
100+ (indicates bleeding problem, cant clot)
clinical uses of PTT test
eval liver function, monitor heparin therapy, detect factor deficiency, detect lupus anticoagulant, detect specific factor inhibitors, monitor unfractionated heparin therapy, monitor direct thrombin inhibitor
a coagulation test that measures protein concentration (NOT functional activity), usually done when PT/INR and PTT are abnormal or when diagnosing hypo/dysfibrinogenemia/DIC/primary fibronolysis
fibrinogen (factor 1) test
what kind of fibrinogen (factor 1) test is most commonly done
clauss assay is most commpnly performed (modified TT)
critical value for fibrinogen (factor 1) test
under 100
high fibrinogen (factor 1) causes
inflammatory, trauma, cancer, meds (aspirin aka salicylate)
low fibrinogen (factor 1) causes
DIC, liver disease, massive blood transfusion, meds (simvostatin, atenolol, prednisolone)
coag test that measures conversion of fibrinogen to fibrin in the common pathway and is sensitive to circulating anticoagulants (heparin)
thrombin time (TT)
how is a fibrin degradation products test done
serum sample collected in special tubes containing thrombin and a trypsin inhibitor that presents break down of fibrinogen in vitro. serum is added to latex particles coated w anti-fibrinogen antibodies
what do fibrin degradation products cause
visible agglutination
test that detects abnormal clotting in blood (not abnormal bleeding)
D-Dimer assay
how is a D-Dimer assay test done
plasma added to latex particles coated w antibodies specific to D-dimers → causes visible agglutination
negative D-Dimer assay =
clot unlikely (yay)
positive D-Dimer assay =
clot has formed and is breaking down (oh no)
when is a D-Dimer assay test used
when thrombotic event (DVT, PE, etc) suspected or when there are signs of DIC
other things that can falsely raise D-Dimer
preg, heart disease, cancer, recent surgery
which test is best for evaluating a defect in the intrinsic pathway
PTT
first screening tests done when theres bleeding concerns
PT and PTT (if abnormal may be an inhibitor or factor deficiency/abnormality)
what can cause abnormal clot formation
activation of coagulation (surgery/cancer/etc), vascular injury (trauma etc), endothelial cell perturbation (radiation therapy etc), down regulation of coagulation regulatory (inhibitor) systems (APCR, plasmin, etc)
warfarin MOA
inhibits carboxylation of vit K dependent coagulation factors (2, 7, 9, 10)
how do we monitor pts on warfarin
monitor their PT/INR
aim for INR of 2-3 or 3-4 if pt has mechanical prosthetic heart valvues or recurrent systemic embolism
heparin MOA
catalyzes inhibition of thrombin, inhibits factor 10a and 9a, inhibits activation of factor 5 and 7 by thrombin, inhibits activation of platelets
how do we monitor pts on heparin
monitor their PTT (1.5-2.5x pts baseline), can cause heaprin indiced thrombocytopenia if too high
low molecular weight heparin MOA
inactivated factor 10a (but doesnt inactivate thrombin much)
how do we monitor pts on LMWH
monitor by factor 10a inhibition assay